These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 30647177

  • 1. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [Abstract] [Full Text] [Related]

  • 2. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
    Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.
    J Autoimmun; 2020 Jan; 106():102340. PubMed ID: 31629628
    [Abstract] [Full Text] [Related]

  • 3. Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE.
    Wirestam L, Frodlund M, Enocsson H, Skogh T, Wetterö J, Sjöwall C.
    Lupus Sci Med; 2017 Jan; 4(1):e000225. PubMed ID: 29188073
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus.
    Kandane-Rathnayake R, Kent JR, Louthrenoo W, Luo SF, Wu YJ, Lateef A, Golder V, Sockalingam S, Navarra SA, Zamora L, Hamijoyo L, Katsumata Y, Harigai M, Chan M, O'Neill S, Goldblatt F, Lau CS, Hoi A, Nikpour M, Morand E.
    Lupus; 2019 Dec; 28(14):1669-1677. PubMed ID: 31718467
    [Abstract] [Full Text] [Related]

  • 5. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [Abstract] [Full Text] [Related]

  • 6. Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus.
    Rullo OJ, Woo JM, Parsa MF, Hoftman AD, Maranian P, Elashoff DA, Niewold TB, Grossman JM, Hahn BH, McMahon M, McCurdy DK, Tsao BP.
    Arthritis Res Ther; 2013 Jan 23; 15(1):R18. PubMed ID: 23343383
    [Abstract] [Full Text] [Related]

  • 7. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
    Urowitz MB, Gladman DD, Ibañez D, Fortin PR, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Sanchez-Guerrero J, Wallace DJ, Ginzler E, Alarcón GS, Merrill JT, Bruce IN, Sturfelt G, Nived O, Steinsson K, Khamashta M, Petri M, Manzi S, Ramsey-Goldman R, Dooley MA, van Vollenhoven RF, Ramos M, Stoll T, Zoma A, Kalunian K, Aranow C.
    Arthritis Care Res (Hoboken); 2012 Jan 23; 64(1):132-7. PubMed ID: 21954226
    [Abstract] [Full Text] [Related]

  • 8. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB, Bae SC.
    Int J Rheum Dis; 2015 Feb 23; 18(2):117-28. PubMed ID: 25524656
    [Abstract] [Full Text] [Related]

  • 9. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov 23; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

  • 10. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
    Kim SK, Choe JY, Lee SS.
    Yonsei Med J; 2018 Sep 23; 59(7):857-864. PubMed ID: 30091319
    [Abstract] [Full Text] [Related]

  • 11. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain RJEM, Zirkzee E, Fritsch-Stork R, Bultink IEM, Kamphuis S.
    Arthritis Rheumatol; 2019 Feb 23; 71(2):290-301. PubMed ID: 30152151
    [Abstract] [Full Text] [Related]

  • 12. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort.
    Bourré-Tessier J, Urowitz MB, Clarke AE, Bernatsky S, Krantz MJ, Huynh T, Joseph L, Belisle P, Bae SC, Hanly JG, Wallace DJ, Gordon C, Isenberg D, Rahman A, Gladman DD, Fortin PR, Merrill JT, Romero-Diaz J, Sanchez-Guerrero J, Fessler B, Alarcón GS, Steinsson K, Bruce IN, Ginzler E, Dooley MA, Nived O, Sturfelt G, Kalunian K, Ramos-Casals M, Petri M, Zoma A, Pineau CA.
    Arthritis Care Res (Hoboken); 2015 Jan 23; 67(1):128-35. PubMed ID: 24838943
    [Abstract] [Full Text] [Related]

  • 13. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi I, Nourse P, Gajjar P, Faller G, Ambaram P, Reuter H, Spittal G, Scott C.
    Lupus; 2017 Feb 23; 26(2):186-194. PubMed ID: 27488473
    [Abstract] [Full Text] [Related]

  • 14. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H, Wetterö J, Skogh T, Sjöwall C.
    Transl Res; 2013 Nov 23; 162(5):287-96. PubMed ID: 23916811
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
    Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Petri M, Steinsson K, Dooley MA, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Urowitz MB.
    Ann Rheum Dis; 2015 Sep 23; 74(9):1706-13. PubMed ID: 24834926
    [Abstract] [Full Text] [Related]

  • 16. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
    Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.
    Arthritis Rheumatol; 2020 Apr 23; 72(4):658-666. PubMed ID: 31631584
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
    Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM.
    Arthritis Rheum; 2002 Feb 23; 46(2):436-44. PubMed ID: 11840446
    [Abstract] [Full Text] [Related]

  • 18. Association of the Systemic Lupus International Collaborating Clinics Frailty Index and Damage Accrual in Longstanding Systemic Lupus Erythematosus.
    Lima K, Legge A, Hanly JG, Lee J, Song J, Chung A, Ramsey-Goldman R.
    Arthritis Care Res (Hoboken); 2023 Mar 23; 75(3):578-584. PubMed ID: 34590445
    [Abstract] [Full Text] [Related]

  • 19. Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients.
    Mosaad NA, Lotfy HM, Farag YM, Mahfouz RH, Shahin RM.
    Immunol Lett; 2017 Jan 23; 181():16-19. PubMed ID: 27838471
    [Abstract] [Full Text] [Related]

  • 20. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO, Corrente JE, Saad-Magalhães C.
    Lupus; 2016 Nov 23; 25(13):1479-1484. PubMed ID: 27230556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.